These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33742370)

  • 1. The Characters of Graphene Oxide Nanoparticles and Doxorubicin Against HCT-116 Colorectal Cancer Cells In Vitro.
    Banoon SR; Ghasemian A
    J Gastrointest Cancer; 2022 Jun; 53(2):410-414. PubMed ID: 33742370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Synergistic Anticancer Traits of Graphene Oxide Plus Doxorubicin Against BT474 and MCF7 Breast Cancer Stem Cells In Vitro.
    Ebrahimi M; Teimouri M; Pooladi M
    Appl Biochem Biotechnol; 2021 Nov; 193(11):3586-3601. PubMed ID: 34324153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of graphene oxide and graphene oxide loaded with doxorubicin on human multiple myeloma cells.
    Wu S; Zhao X; Cui Z; Zhao C; Wang Y; Du L; Li Y
    Int J Nanomedicine; 2014; 9():1413-21. PubMed ID: 24672235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Didox and resveratrol sensitize colorectal cancer cells to doxorubicin via activating apoptosis and ameliorating P-glycoprotein activity.
    Khaleel SA; Al-Abd AM; Ali AA; Abdel-Naim AB
    Sci Rep; 2016 Nov; 6():36855. PubMed ID: 27841296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of graphene oxide by angiopep-2 enhances anti-glioma efficiency of the nanoscaled delivery system for doxorubicin.
    Zhao Y; Yin H; Zhang X
    Aging (Albany NY); 2020 May; 12(11):10506-10516. PubMed ID: 32474457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graphene oxide induces autophagy and apoptosis via the ROS-dependent AMPK/mTOR/ULK-1 pathway in colorectal cancer cells.
    Shen J; Dong J; Shao F; Zhao J; Gong L; Wang H; Chen W; Zhang Y; Cai Y
    Nanomedicine (Lond); 2022 Apr; 17(9):591-605. PubMed ID: 35394351
    [No Abstract]   [Full Text] [Related]  

  • 7. Cinnamaldehyde and Doxorubicin Co-Loaded Graphene Oxide Wrapped Mesoporous Silica Nanoparticles for Enhanced MCF-7 Cell Apoptosis.
    Dong K; Zhao ZZ; Kang J; Lin LR; Chen WT; Liu JX; Wu XL; Lu TL
    Int J Nanomedicine; 2020; 15():10285-10304. PubMed ID: 33376322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selenium Overcomes Doxorubicin Resistance in Their Nano-platforms Against Breast and Colon Cancers.
    Abd-Rabou AA; Ahmed HH; Shalby AB
    Biol Trace Elem Res; 2020 Feb; 193(2):377-389. PubMed ID: 31066020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance.
    Ashrafizadeh M; Saebfar H; Gholami MH; Hushmandi K; Zabolian A; Bikarannejad P; Hashemi M; Daneshi S; Mirzaei S; Sharifi E; Kumar AP; Khan H; Heydari Sheikh Hossein H; Vosough M; Rabiee N; Kumar Thakur V; Makvandi P; Mishra YK; Tay FR; Wang Y; Zarrabi A; Orive G; Mostafavi E
    Expert Opin Drug Deliv; 2022 Apr; 19(4):355-382. PubMed ID: 35152815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system.
    Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S
    J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin modified graphene oxide for pH-sensitive sustained release of doxorubicin hydrochloride.
    Zhang B; Yang X; Wang Y; Zhai G
    Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():198-206. PubMed ID: 28415455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin and doxorubicin co-delivered via a functionalized graphene-dendrimeric system enhances apoptosis of osteosarcoma cells.
    Niu G; Yousefi B; Qujeq D; Marjani A; Asadi J; Wang Z; Mir SM
    Mater Sci Eng C Mater Biol Appl; 2021 Feb; 119():111554. PubMed ID: 33321618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide.
    Lv Y; Tao L; Annie Bligh SW; Yang H; Pan Q; Zhu L
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():652-660. PubMed ID: 26652419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEGylated nano-graphene oxide as a nanocarrier for delivering mixed anticancer drugs to improve anticancer activity.
    Pei X; Zhu Z; Gan Z; Chen J; Zhang X; Cheng X; Wan Q; Wang J
    Sci Rep; 2020 Feb; 10(1):2717. PubMed ID: 32066812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing the cytotoxic efficacy of combined effect of doxorubicin and Cyclosporin encapsulated photoluminescent graphene dotted mesoporous nanoparticles against lung cancer cell-specific drug targeting for the nursing care of cancer patients.
    Chen F; Zhang H; Jiang L; Wei W; Liu C; Cang S
    J Photochem Photobiol B; 2019 Sep; 198():111578. PubMed ID: 31408842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of biotin molecule targeted cancer cell drug delivery of doxorubicin loaded κ-carrageenan grafted graphene oxide nanocarrier.
    Vinothini K; Rajendran NK; Munusamy MA; Alarfaj AA; Rajan M
    Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():676-687. PubMed ID: 30948104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cRGD-decorated biodegradable polytyrosine nanoparticles for robust encapsulation and targeted delivery of doxorubicin to colorectal cancer in vivo.
    Gu X; Wei Y; Fan Q; Sun H; Cheng R; Zhong Z; Deng C
    J Control Release; 2019 May; 301():110-118. PubMed ID: 30898610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Anticancer Effect of a Conjugated Antimicrobial Peptide Against Colorectal Cancer (CRC) Cells.
    Saleh RO; Essia INA; Jasim SA
    J Gastrointest Cancer; 2023 Mar; 54(1):165-170. PubMed ID: 35217999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypericin-functionalized graphene oxide for enhanced mitochondria-targeting and synergistic anticancer effect.
    Han C; Zhang C; Ma T; Zhang C; Luo J; Xu X; Zhao H; Chen Y; Kong L
    Acta Biomater; 2018 Sep; 77():268-281. PubMed ID: 30006311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro cytotoxicity of GO-DOx on FaDu squamous carcinoma cell lines.
    Singh M; Gupta P; Baronia R; Singh P; Karuppiah S; Shankar R; Dwivedi PD; Singh SP
    Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):107-111. PubMed ID: 29593407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.